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Abstract 27 
Objective: The aim of the study was to assess the convergent and divergent validity, reliability, 28 
utility, and treatment sensitivity of a newly-translated German version of the Southampton 29 
Mindfulness Questionnaire (SMQ). The SMQ is a 16-item instrument measuring mindful 30 
awareness of distressing thoughts, images, and perceptions, developed originally within the 31 
mindfulness for psychosis field. 32 
Methods: Overall, three studies were conducted, comprising (1) a non-clinical sample of n = 33 
848 (638 community-sample and 210 meditators); (2) a clinical sample of n = 213 (106 34 
schizophrenia and 107 depression); and (3) a clinical sample with n = 122 participants with 35 
emotional disorders within a randomized controlled study, of which 30 participants were also 36 
included in Study 2. To assess convergent validity, participants completed the SMQ, Freiburg 37 
Mindfulness Inventory (FMI), and Comprehensive Inventory of Mindfulness Experiences 38 
(CHIME). To measure divergent validity, participants completed the Brief-Symptom-Inventory 39 
18 (BSI-18), Positive and Negative Affect Schedule (PANAS), Brief Experiential Avoidance 40 
Questionnaires (BEAQ), and Anxiety Sensitivity Index 3 (ASI-3).  41 
Results: Mean internal consistency (α = .89), convergent- (r = .66 to .73), and divergent validity 42 
(r = -.09 to -.50) were established and sensitivity to change over time following treatment (d = 43 
.86) was shown. For the clinical sample, a single-factor structure is suggested by Principle 44 
Component Analysis. 45 
Conclusion: Results provide first evidence for the utility of the German version of the SMQ for 46 
clinical practice and research in healthy individuals, meditators, and clinical groups. Further 47 
research is needed to examine the underlying construct of mindfulness. 48 
Keywords: validation, Southampton mindfulness questionnaire, SMQ, mindfulness, 49 
schizophrenia, depression 50 
  51 
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Validation of the German version of the Southampton mindfulness 52 
questionnaire (SMQ) 53 
 54 
Converging evidence for the effectiveness of mindfulness practices demonstrates the 55 
importance of developing novel, reliable, and valid tools to measure mindfulness states and 56 
traits (Baer 2007). In several English-speaking countries, a variety of mindfulness 57 
questionnaires and tools already exist (Baer et al., 2004, 2006; Brown & Ryan, 2003; Feldman 58 
et al., 2007). In Germany, however, only a handful of well-validated self-report mindfulness 59 
questionnaires (Mindful Attention and Awareness Scale (MAAS), Freiburg Mindfulness 60 
Inventory (FMI), Kentucky Inventory of Mindfulness Skills (KIMS), Five Facet Mindfulness 61 
Questionnaire (FFMQ), and Comprehensive Inventory of Mindfulness Experiences CHIME)) 62 
are available and these show various limitations (Heidenreich et al. 2006). These limitations 63 
comprise comprehension difficulties for several items that were misunderstood by mindfulness 64 
inexperienced participants due to their complex wording, as reported for the FMI (Belzer et al., 65 
2013) and FFMQ (Christopher et al., 2014). Furthermore, the MAAS was criticized for 66 
assessing the construct of mindlessness instead of mindfulness (Sauer et al. 2011). The CHIME 67 
avoids complex wording and assesses eight related domains of mindfulness. It comprises 37 68 
items and is therefore considerably longer than other mindfulness questionnaires. Furthermore, 69 
the CHIME, similar to the other mindfulness questionnaires, does not provide a neutral answer 70 
opportunity (“undecided”). This might be overstraining, especially for clinical populations that 71 
frequently experience cognitive deficits and might not understand all items. For this reason, it 72 
is crucial to create psychometrically sound and accurate measures of mindfulness that can 73 
facilitate a deepened understanding of its underlying mechanisms as well as the psychological 74 
and therapeutic processes involved (Bishop et al., 2004; Brown & Ryan, 2004; Dimidjian & 75 
Linehan, 2003). This is particularly relevant for research in emerging areas, such as mindfulness 76 
VALIDATION OF THE GERMAN SOUTHAMPTON MINDFULNESS QUESTIONNAIRE 4 
 
for psychosis, which currently has a less well-established evidence base compared to other 77 
disorders, such as Mindfulness-Based Cognitive Therapy (MBCT) for depression. 78 
The Southampton Mindfulness Questionnaire (SMQ) is a 16-item inventory assessing the 79 
degree to which individuals mindfully respond to distressing thoughts, images, and perceptions 80 
that constitute key psychopathological phenomena in various clinical disorders (Chadwick et 81 
al., 2008). It was specifically designed to support the outcome and research process in 82 
mindfulness for psychosis, although it is applicable transdiagnostically and in non-clinical as 83 
well as clinical populations. It consists of four related bipolar constructs converged to a 84 
unidimensional trait-like tendency to be mindful in daily life (Chadwick et al., 2008, 2005). 85 
Those components are: (1) decentered awareness (Safran & Segal, 1990) of cognitions vs. being 86 
lost in reacting to them, (2) non-aversion vs. experiential avoidance (Chadwick et al., 2008), (3) 87 
non-judgment & acceptance of difficult thoughts of oneself (Kabat-Zinn, 1990, p. 69), and (4) 88 
letting difficult cognitions pass without rumination and worry (Chadwick et al., 2008). By 89 
including multiple facets of mindfulness constructs, on the one hand, the SMQ covers not all, 90 
but a wide range of aspects when compared to the MAAS (Grossman, 2011; Höfling et al., 91 
2011). On the other hand, the scale also retains its simplicity due to its single-factor structure 92 
(Bergomi et al., 2013). 93 
 The SMQ has thus been selected for German translation and adaptation because of its 94 
suitability for assessments in clinical practice and research by focusing on the mindful 95 
relationship with distressing thoughts and images - a central phenomenon in clinical disorders 96 
such as schizophrenia or depression (Bergomi et al., 2013; Chadwick et al., 2008). Therefore, 97 
the SMQ might be suitable to measure mindfulness as an underlying mechanism of change in 98 
psychotherapy (Bergomi et al., 2013). Chadwick et al. (2008) have shown that the scale has 99 
good convergent validity with the MAAS (r = .61), divergent validity between meditators, non-100 
meditators, and a clinical group of people with schizophrenia as well as internal consistency (α 101 
= .89). Furthermore, the SMQ features homogenous item interpretation for meditators and non-102 
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meditators (Chadwick et al., 2008). In contrast to other available mindfulness measures, the 103 
SMQ provides a neutral answer option (3 “undecided”) and has a wide distribution of response 104 
categories ranging from 0 “disagree totally” to 6 “agree totally”. This allows for more diverse 105 
response patterns, which might be explicitly valuable in clinical populations. Henceforth, the 106 
translated and validated SMQ might constitute a useful transdiagnostic tool for the assessment 107 
of mindfulness in psychotic and affective disorders, which are both among the three most 108 
prevalent psychiatric conditions in German hospitals (DGPPN, 2018).  109 
The overall aim of the present study was to translate the SMQ into German, and to 110 
examine its validity, reliability, utility, and treatment sensitivity. This validation study 111 
comprises three sub-studies: Study 1 focused on the validation of the German SMQ within a 112 
non-clinical sample, comparing meditators to non-meditators, recruited for an online study from 113 
the general population. Study 2 focused on the validation within a clinical sample of people 114 
diagnosed with either depression or schizophrenia, recruited from inpatient and community 115 
mental health services. Finally, Study 3 focused on the sensitivity to change over time of the 116 
German SMQ, using data from a randomized controlled trial of an online psychological therapy 117 
for people with common mental health problems. 118 
 119 
Study 1 120 
The Southampton Mindfulness Questionnaire (SMQ, Chadwick et al., 2005) is a 16-121 
item scale assessing the degree to which individuals mindfully respond to distressing thoughts 122 
and images (Chadwick et al., 2005). The questionnaire comprises eight positively- and 123 
negatively-worded items rated on a 7-point fully-anchored Likert scale (agree totally (6) to 124 
disagree totally (0)), yielding a total score range of 0 - 96. The SMQ is designed to assess four 125 
related aspects of mindfulness that are constructed as bipolar items: 1) decentered awareness, 126 
2) letting go, 3) nonjudgment, 4) non-aversion, but exploratory factor analyses recommended 127 
a one-dimensional factor structure (Chadwick et al., 2008, 2005). All items are introduced with 128 
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the phrase “Usually, when I have distressing thoughts or images …” and continue with a 129 
mindfulness-related response, such as, “I judge the thought/image as good or bad” or “I am able 130 
just to notice them without reacting”. The SMQ validated in this publication was first translated 131 
by two German native speaking psychologists from English to German. Next, two independent 132 
English native speaking psychologists translated both versions to English, employing current 133 
back translation standards (WHO, 2014). Pilot-testing was performed by three independent 134 
samples of people with schizophrenia, depression, and a healthy control group. Lastly, all four 135 
versions were checked according to the World Health Organization (2014) guidelines for the 136 
‘Process of translation and adaptation of instruments' to ensure the equivalence of the 137 
questionnaires. In Study 1, it was aimed to determine the reliability, factor structure, and 138 
convergent validity of the SMQ in a non-clinical sample. Therefore, a large non-clinical 139 
community sample comprising regular meditators as well as non- meditators was recruited. In 140 
the original validation study, the SMQ depicted an overall single factor structure even though 141 
the measure consists of four related constructs (Chadwick et al., 2008). Moreover, in a non-142 
clinical community sample, the SMQ depicted good reliability and convergent validity with 143 
other mindfulness measures (Baer et al., 2006; Chadwick et al., 2008). Given the emphasis in 144 




Participants  149 
In the study, 210 meditators (162 women, 47 men, 1 non-binary) with a mean age of 39.57 150 
(SD = 12.34; range = 21 - 68) participated. The majority of the meditating sample were German 151 
(n = 166), single (n = 124) or married (n = 50), held a university degree (n = 112), completed 152 
an apprenticeship (n = 26) or reported a high-school graduation as their highest degree (n = 36). 153 
Most of the meditating participants were currently employed (n = 81), self-employed (n = 53), 154 
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or studying (n = 51). Participants were included as meditators if they reported a mediation 155 
practice of at least one hour per week over the last month in order to recruit a sample with a 156 
wide spectrum of meditation experience. On average, meditators had 60.17 (SD = 90.18; range 157 
1 - 559) months of meditation experience and meditated on average 4.72 (SD = 5.37, range 1 - 158 
36h) hours per week. Out of these, 46 participants had meditation experience of six months or 159 
less (M = 49.94, SD = 16.21), 60 were meditating for a period of six months to two years (M = 160 
55.57, SD = 12.89), 21 between two and three years (M = 65.43, SD = 13.35), and 83 were 161 
meditating for more than three years prior to the study (M = 61.9,  SD = 14.12). The community 162 
sample comprised 638 participants (549 women, 85 men, 4 non-binary) with a mean age of 163 
30.26 (SD = 10.81; range 18 - 76). Participants from this sample were mostly German (n = 507), 164 
single (n = 498) or married (n = 111), and held a high-school degree (n = 242) or a university 165 
degree as their highest education (n = 292). The majority of participants in this sample were 166 
currently employed (n = 157) or studying (n = 389). Out of the undergraduates and graduates, 167 
the majority were students of humanities (n = 360), of which n = 332 were psychology, or 168 
medicine students (n = 87). 169 
Procedure 170 
The non-clinical sample was recruited via an online questionnaire created with Unipark 171 
Software Questback. Via various routes, students and alumni from universities in German-172 
speaking countries (Germany, Austria, Switzerland) were approached via mailing lists with a 173 
focus on psychology, medicine, and other closely related fields. In addition, meditation and 174 
mindfulness centers throughout German-speaking countries were approached with the request 175 
to forward the study.  176 
Measures 177 
In addition to completing the newly-translated German version of the SMQ (see Table 1), 178 
participants completed 2 additional mindfulness measures for the purposes of assessing 179 
convergent validity.  180 
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Freiburg Mindfulness Inventory Short Form (FMI; Buchheld et al.,, 2001). The 181 
construction of the Freiburg Mindfulness Inventory Short Form (FMI) was particularly inspired 182 
by the Buddhist roots of the construct and consists of 30 items assessing non-judgmental 183 
present-moment observation and openness to negative experiences (Buchheld et al., 2001). The 184 
FMI short form is a robust 14-item instrument, which is semantically independent of a Buddhist 185 
context, but still covers all aspects of mindfulness, making it more appropriate for use in the 186 
general and clinical population (Walach et al., 2006). Items are rated on a 4-point Likert-type 187 
scale (rarely (1) to almost always (4)), yielding a total range of 14 – 56. It has a two-dimensional 188 
structure, comprising an acceptance and a presence factor (Heidenreich et al., 2006; Kohls et 189 
al., 2009). Despite the efforts to remove the close semantic Buddhism link, a qualitative analysis 190 
showed that individuals without meditation experience systematically misunderstood three 191 
items (Belzer et al., 2011). In the current study, the Cronbach’s α of the total sample was .88. 192 
Comprehensive Inventory of Mindfulness Experiences (CHIME; Bergomi et al., 2014). 193 
The Comprehensive Inventory of Mindfulness Experiences (CHIME) is a multidimensional 194 
questionnaire providing broad coverage of mindfulness. It comprises eight subscales: inner 195 
awareness, outer awareness, acting with awareness, openness to experiences, accepting and non-196 
judgmental orientation, decentering and non-reactivity, insightful understanding, and relativity 197 
of thoughts. The factor structure proved to be stable over three samples and validity analyses 198 
provided good results (Bergomi et al., 2014). It comprises 37 items, scored on a 6-point Likert-199 
type scale (almost never (1) to almost always (6)), yielding a total range of 37 - 222. The 200 
construction of the CHIME puts a major focus on items being as semantically precise as possible 201 
for different population subgroups by avoiding ambiguous words such as meditation-related 202 
idioms. The Cronbach’s α for the total sample in this study was .92. 203 
Data Analyses 204 
 All analyses were carried out using IBM SPSS Statistics 24 and R version 3.6.0 including 205 
the packages “semTools” (Jorgensen et al., 2020) and “lavaan” (Rosseel, 2012). Outliers were 206 
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identified using boxplots and stem-and-leaf plots on SMQ total scores as well as subscores, and 207 
were removed from statistical analyses if they were outside the +/-1.5 interquartile range (IQR). 208 
Individuals were outside this 1.5 IQR if their SMQ score was ≤ 5 or ≥ 91. Furthermore, one 209 
individual was removed with a score of ≥ 23 on the SMQ subdomain letting go. Consequently, 210 
for the analysis of the total sample, five outliers were excluded, for the analysis of the non-211 
clinical sample four, and for the analysis of the clinical sample one outlier was removed. 212 
Kolmogorov-Smirnow test of normality was applied with additional visual inspection of 213 
histogram and Q-Q plot to assess normality. Each item’s psychometric performance was 214 
assessed by response frequencies and internal consistency was determined by calculation of 215 
Cronbach’s alpha. Pearson’s correlation coefficient r was computed for SMQ, FMI and CHIME 216 
scores to assess convergent validity. Bartlett’s sphericity test was used to determine the 217 
applicability of a factorial model on the sample. The Kaiser-Meyer-Olkin (KMO) statistic was 218 
examined to compare the correlations between variables. KMO values close to one display 219 
appropriateness while in cases for which the KMO index is closer to zero, no factor analysis 220 
should be conducted. In a next step, a single-factor-solution and a four-factor solution 221 
(Observing, Letting-go, Non-judgment and Non-Aversion) as proposed by Chadwick et al. 222 
(2008) were tested by confirmatory factor analysis (CFA) with diagonally weighted least 223 
squares estimation (DWLS). Assessed model fit indices included Chi-square (χ2), Root Mean 224 
Square Error Of Approximation (RMSEA), Confirmatory Factor Index (CFI), and 225 
(Standardized) Root Mean Square Residual (SRM; Kline, 2015). In addition, measurement 226 
invariance analysis was conducted to assess whether the meaning of the items is comprehended 227 
differently between the clinical and the non-clinical group (Sass, 2011). Lastly, a chi-square 228 
difference test was performed comparing the one- and four-factor solution in order to compare 229 
the fit of the two models. The level of significance for all analyses was set at α = .05. 230 
 231 
Results 232 
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 Table 2 and Table 3 show the SMQ item means, item standard deviations, and one- as 233 
well as four-factor-model loadings for the non-clinical sample (638 community-sample and 210 234 
meditators). The mean SMQ-score for the non-clinical sample (n = 848) is 49.23 (SD = 15.20). 235 
Cronbach’s α was .91, indicating excellent internal consistency. For exploratory reasons, the 236 
classification criteria for the meditating sample were set to eight-weeks of meditation 237 
experience, which corresponds to classical MBSR and MBCT therapy programs. When 238 
compared with the four week experience criteria applied previously, the SMQ scores for the 239 
two non-clinical samples remain fairly similar: within the community sample, the mean SMQ 240 
score changes from 46.40 to 46.49 (SD = 14.22) and for the meditators, the mean shifts from 241 
57.82 to 58.52 (SD  = 14.76). 242 
Kolmogorov-Smirnov test of normality (Z = 0.04; p = .008) indicated non-normality 243 
while visual inspections indicate that the distributions are fairly normal, which suggests that the 244 
assumptions for using parametric tests seem to be met (Öztuna et al., 2006). Bartlett’s test of 245 
sphericity, testing the overall significance of the correlations within the correlation matrix, was 246 
significant (χ² (120) = 5681.343, p < .001), indicating that applying a factorial model on the 247 
sample is appropriate. The Kaiser–Meyer–Olkin statistic indicates high strength of correlation 248 
among variables (KMO = .935), thus the sample is considered suitable for subsequent factor 249 
analysis. For the one-factor model, CFA indicates χ² (104, n = 848) = 1450.52, p < .001; RMSEA 250 
= .124, p < .001; CFI = .907; and SRMR = .064. The four-factor solution displays χ²(98, n = 251 
848) = 1177.79, p < .001; RMSEA = .114, p < .001; SRMR = .058; and CFI = .926. These 252 
results indicate a better fit of the four-factor solution, which, however, still not displays good fit 253 
(Hooper et al., 2008). The Chi-square difference test indicates the two models to be significantly 254 
different (p < .001). 255 
  Correlations of SMQ-scores with FMI-scores (r = .71, p < .01) and CHIME-scores (r = 256 
.78, p < .01) indicate strong convergent validity for the non-clinical sample (see Table 4). T-257 
testing revealed that individuals with current meditation practice of four weeks (t(846) = -9.978, 258 
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p < .001) score significantly higher on the SMQ (M = 57.82, SD = 15.05) compared to non-259 
meditators (M = 46.40, SD = 14.16). Furthermore, for exploratory reasons, correlations between 260 
SMQ scores and the number of hours someone meditates per week (r = .23, p < .001), as well 261 
as the number of hours a person practices mindfulness (r = .29, p < .001) were assessed within 262 
the meditation sample.  263 
 264 
Discussion 265 
Study 1 provided further evidence for the utility of the SMQ in a non-clinical sample. It 266 
shows excellent internal consistency and reliability as well as strong convergent validity with 267 
two frequently used and well-validated mindfulness measures in clinical practice and research. 268 
Moreover, a positive relationship was assessed between SMQ scores and frequency as well as 269 
duration of meditation practice. In addition, data indicated that the SMQ discriminates well 270 
between meditators and non-meditators, suggesting its generalizability to a wide non-clinical 271 
population. All outcomes are consistent with previous trials, but similarly could neither confirm 272 
a single-factor nor a four-factor structure. Therefore, further research is needed to examine the 273 
construct of mindfulness (Baer et al., 2006; Chadwick et al., 2008). 274 
 275 
Study 2 276 
The overall aim of Study 2 was, analogous to Study 1, to measure reliability, factor 277 
structure, and convergent validity of the SMQ, however, in a clinical sample including patients 278 
diagnosed with schizophrenia and depression. In a previous validation trial, the SMQ showed 279 
good internal consistency, adequate concurrent validity, and discriminated well between a non-280 
clinical sample and individuals with psychosis (Chadwick et al., 2008). Moreover, it was shown 281 
that mindfulness abilities were inversely related to intensity of delusional experiences and 282 
negative affect (Chadwick et al., 2008). Therefore, Study 2 examined these psychometric 283 
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properties in a larger clinical sample including in- and outpatient with schizophrenia, as well as 284 




Participants  289 
In the clinical samples, 54 participants with schizophrenia were inpatients, and 52 were 290 
outpatients, all in treatment at a university hospital in Berlin (study site 1). Of the depressive 291 
sample, 77 were patients at the university hospital inpatient ward (study site 1). Moreover, of 292 
all participants recruited (study site 2) for Study 3, 30 with a depression diagnosis were also 293 
included into the present clinical sample, resulting in a sample of 107 participants with 294 
depression (see Figure 1). The total clinical sample therefore comprised 213 participants (126 295 
women, 86 men, 1 non-binary), with a mean age of 43.18 (SD = 14.57; range 18 - 80). For the 296 
106 participants with schizophrenia (65 women, 40 men, 1 diverse gender) the mean age was 297 
42.12 (SD = 13.19; range 20 – 71), and for the 107 depressive participants (61 women, 46 men), 298 
the mean age was 44.23 (SD = 15.82; range 18-80). In- and outpatients did not differ in regard 299 
to any demographic variables (age, duration of illness, gender). Further analyses were conducted 300 
concerning gender, occupation, and family status. There were, however, no statistically 301 
significant differences between any of the subsamples on the sociodemographic variables 302 
assessed. Overall, the majority of the clinical sample was German (n = 162), single (n = 130) or 303 
married (n = 28), and already retired (n = 63), currently employed (n = 44), or seeking work (n 304 
= 42). A number of n = 33 achieved a university degree, n = 42 completed an apprenticeship, n 305 
= 42 completed high-school, and n = 48 achieved an intermediate school-leaving certificate. 306 
Procedure 307 
For the clinical sample, inclusion criteria were defined as speaking German, being able to 308 
understand and fill out the questionnaires, providing written informed consent prior 309 
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participation, and a diagnosis of either F.2 spectrum (schizophrenia) or F.3 spectrum 310 
(depressive disorders) (American Psychiatric Association, 2000, 2013). All diagnoses were 311 
determined according to ICD-10 or DSM-5 criteria by either a licensed psychiatrist, 312 
psychologist, and/or consulting psychiatrist through a semi-structured interview (DIPS) which 313 
is conducted routinely with every patient at the in- and outpatient facility of the university 314 
hospital. 315 
Measures 316 
The same questionnaires as in Study 1 were assessed, including the SMQ, FMI, and 317 
CHIME. 318 
Data Analyses 319 
The statistical analysis of Study 2 is consistent with the analysis described in Study 1, 320 
besides the difference concerning the investigated sample population. However, no 321 
confirmatory factor analysis (CFA) was conducted, as the sample size of the clinical population 322 
in this study was too small for examining a four-factor structure (Wolf et al., 2013). Therefore, 323 
construct validity was evaluated by exploratory component factor analysis (EFA) with varimax 324 
rotation to explore the factor structure of the SMQ.  325 
 326 
Results 327 
Table 3 illustrates the SMQ item means, item standard deviations, corrected item-total 328 
correlations, R-Square, and rotated factor loadings for the clinical sample (106 schizophrenia 329 
and 107 depression). The mean SMQ-score for the clinical sample (n = 213) was 42.35 (SD = 330 
13.03). For the schizophrenia spectrum subsample, the mean SMQ-score was 45.58 (SD = 331 
11.21), whereas for the depressive disorders subsample (n = 107), the mean score was 39.15 332 
(SD = 13.93). Furthermore, among the clinical outpatients (n = 82), SMQ-scores had a mean of 333 
42.71 (SD = 12.51), compared to inpatients (n = 131), who scored with a mean of 42.13 (SD = 334 
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13.38). The SMQ showed a Cronbach’s α of .80, stating good internal consistency with 335 
corrected item-total correlations having a mean of .40 (range .12 - .61) for the clinical sample. 336 
For the clinical sample, the Kolmogorov-Smirnov test of normality was insignificant (Z 337 
= 0.04; p = .20) and visual inspections indicated that the distributions are fairly normal. 338 
Bartlett’s test of sphericity was significant (χ2 (120) = 1006.557, p < .001). The Kaiser–Meyer–339 
Olkin statistic indicated a high correlation among variables (KMO = .821). EFA revealed that 340 
four factors are relevant to explain the structure of the SMQ. Factors 1,2,3, and 4 had 341 
eigenvalues of 4.31, 2.67,1.29, and 1.00, respectively, and accounted for 26.93, 16.67, 8.05, 342 
and 6.29% of variance. Although four factors have eigenvalues above one and two account for 343 
43% of the variance, an examination of the scree plot strongly suggests a two-factor structure. 344 
When attempting to interpret the two factor-solution, however, no interpretable two-factor 345 
structure could be formulated. It is a common occurrence that when dealing with clinical 346 
samples, uninterpretable factor structures are the result of factor analyses (Floyd & Widaman, 347 
1995).  348 
Correlations between SMQ-scores and FMI-scores (r = .38, p < .01) as well as CHIME-349 




The current findings are in line with the original validation study, demonstrating the 354 
SMQ’s reliability and convergent validity with other mindfulness measures in clinical 355 
populations (Chadwick et al., 2008). Furthermore, these are the first empirical data to show 356 
these outcomes in out- and inpatients with schizophrenia as well as depression, supporting 357 
clinical and research utility of the SMQ for a variety of clinical disorders. Aligned with 358 
Chadwick et al. (2008), the SMQ seems to display a one-factor structure, however, further 359 
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research needs to establish the measures with other clinical groups and examine its underlying 360 
construct. 361 
 362 
Study 3 363 
The original validation study of the SMQ investigated the measures divergent validity 364 
in regard to positive and negative affect as well as psychotic symptoms in a sample of psychotic 365 
patients (Chadwick et al., 2008). Since mindfulness is discussed as an important process in 366 
emotional disorders and frequently targeted in psychotherapy, the aim of Study 3 was to further 367 
broaden the understanding of the SMQ’s relation to bordering constructs and sensitivity to 368 
change following psychological treatment. To achieve this, the SMQ’s relation to symptom 369 
distress, positive and negative affect, experiential avoidance, and anxiety sensitivity was 370 
investigated using outcome data from an internet-based treatment for emotional disorders. This 371 
investigation was part of an ongoing randomized waitlist-controlled trial on an internet-based 372 
transdiagnostic treatment for emotional disorders (conducted at study site 2) (registered as 373 
DRKS00014820 in the German Clinical Trials Register DRKS). Participants were randomized 374 
to receive a 10-week guided transdiagnostic intervention based on the Unified Protocol (Barlow 375 
et al., 2018) or to a wait-list control. The Unified Protocol postulates mindful emotional 376 
awareness as one of the underlying mechanisms for symptom reduction. Accordingly, the third 377 
week of the internet-based program focuses on mindfulness and encourages participants to 378 
practice mindfulness with a selection of mindfulness exercises. Other modules include 379 
motivation and goal setting (week 1), psychoeducation on emotions (week 2), cognitive 380 
restructuring (week 4 & 5), interoceptive and in vivo exposure (week 6 - 9), and relapse 381 
prevention (week 10). Participants work through the ten modules independently and receive 382 
weekly feedback from trained and supervised online therapists.  383 
Participants  384 
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Of the 122 participants that took part in the study, 55 participants were diagnosed with 385 
a primary diagnosis of depression, 59 participants with a primary anxiety disorder, and 8 386 
participants with a primary somatic symptom disorder (see Figure 1). Participants (83 women, 387 
39 men) were, on average, 37.32 years old (SD = 12.49, range 18 - 67). If participants fulfilled 388 
the inclusion criteria, they were randomized to the treatment group or the wait-list control 389 
group. To examine the SMQ’s sensitivity to change, the change in mindfulness between 390 
participants in the treatment group and the waitlist group was compared. The SMQ was assessed 391 
at baseline prior to randomization, after the mindfulness module / week 3, and after the 10-392 
week intervention / waiting period. Of the n = 122 participants, all filled out the baseline 393 
assessment; n = 51 of the treatment group and n = 46 of the waitlist condition filled out the 394 
module / week 3 assessment, and n = 36 of the treatment and n = 52 of the waitlist filled out 395 
the post-intervention / waiting period assessment. Overall, n = 35 of the treatment group and n 396 
= 45 of the waitlist condition filled out the SMQ at all three time points and were included in 397 
the complete analysis. Of the n = 35 participants in the treatment group, n = 15 had a principal 398 
anxiety, n = 18 a principal depressive, and n = 2 a principal somatic symptom disorder. Of the 399 
n = 45 participants in the waitlist group, n = 23 had a principal anxiety, n = 18 a principal 400 
depressive and n = 4 a principal somatic symptom disorder. The trial is still ongoing and n = 8 401 
are currently still in treatment and thus could not be included in the analysis. 402 
Procedure 403 
Participants of the randomized controlled trial were recruited through mental health 404 
forums as well as on social media platforms. Diagnoses were determined with a structured 405 
diagnostic interview (Margraf et al. 2017) via telephone. 406 
Measures 407 
In addition to the SMQ, the following measures were assessed the following measures 408 
in the baseline assessment: 409 
Brief Symptom Inventory 18 (BSI-18; Derogatis, 2001; Franke et al., 2011) 410 
VALIDATION OF THE GERMAN SOUTHAMPTON MINDFULNESS QUESTIONNAIRE 17 
 
The Brief-Symptom-Inventory (BSI 18) is an 18-item short-version of the Symptom-411 
Checklist-90-R. The BSI-18 assesses symptom distress with three 6-item subscales depression, 412 
anxiety, and somatization. Items are rated on a 5-point Likert-type scale (not at all (0) to 413 
extremely (4)), yielding a total score for the General Symptom Index from 0 to 72 (Derogatis, 414 
2001). Confirmatory factor analysis supported the 3-factor-structure (Franke et al., 2011; Prinz 415 
et al., 2013). The BSI-18 and the subscales show high internal consistency and overall 416 
satisfactory psychometric properties (Derogatis & Fitzpatrick, 2004; Franke et al., 2011; Prinz 417 
et al., 2013). The Cronbach’s α of the BSI-18 in the current study was .82. 418 
Positive and Negative Affect Schedule (PANAS, Krohne et al., 1996; Watson et al., 1988) 419 
The Positive and Negative Affect Schedule (PANAS) measures positive and negative 420 
affect with two quasi-independent 10-item scales. Participants rate to what extent they 421 
experienced an affect, e.g. “active” or “afraid”, on a 5-point Likert-type scale (very slightly or 422 
not at all (1) to extremely (5)), yielding a total score for positive as well as negative affect from 423 
10-50. Both scales show high internal consistency as well as convergent and divergent validity 424 
(Watson et al., 1988). In the current study, for the positive affectivity scale, Cronbach’s α was 425 
.83 and for the negative affectivity scale .85.  426 
Brief Experiential Avoidance Questionnaire (BEAQ, Gámez et al., 2014) 427 
The Brief Experiential Avoidance Questionnaire (BEAQ, Gámez et al., 2014), a short 428 
version of the Multidimensional Experiential Avoidance Questionnaire (Gámez et al., 2011), 429 
assesses experiential avoidance as a broad construct with 15 items. Items are rated on a 6-point 430 
Likert-type scale (strongly disagree (1) to strongly agree (6)), yielding a total score from 15-431 
90. The measure covers several aspects of experiential avoidance like explicit avoidance 432 
behavior and attitudes in regard to distress. The BEAQ is internally consistent and can be 433 
distinguished from negative emotionality (Gámez et al., 2014). For Study 3, the BEAQ was 434 
translated to German and validated in a German student (N = 596) and clinical outpatient (N = 435 
53) sample. Internal consistency in both samples was good (α = .81 in the student and α = .87 436 
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in the clinical sample) and expected correlations to convergent and divergent measures 437 
supported its validity (please contact the second author for detailed information on the German 438 
translation of the BEAQ). In the current study, Cronbach’s α for the BEAQ was .74. 439 
Anxiety Sensitivity Index 3 (ASI-3, Kemper et al., 2009; Taylor et al., 2007) 440 
The Anxiety Sensitivity Index 3 (ASI-3, Kemper et al., 2009; Taylor et al., 2007) 441 
assesses anxiety sensitivity – the fear of arousal-related bodily symptoms – with 18 items. Items 442 
are rated on a 4-point Likert-type scale (very little (0) to very much (4)), yielding a total score 443 
from 0 to 72. The ASI-3 has a three-factor-structure with the subscales Physical-, Cognitive-, 444 
and Social Concern, and satisfactory psychometric qualities (Taylor et al., 2007). In the current 445 
study, the ASI-3 had an internal consistency of Cronbach’s α = .88. 446 
 447 
Data Analyses 448 
Statistical Analyses were performed using IBM SPSS Statistics 25. To analyze 449 
divergent validity, correlations were calculated between the SMQ and the BSI’s total score and 450 
subscales (depression, anxiety, and somatization), the positive and negative affect scale of the 451 
PANAS, the BEAQ, and ASI-3. To explore the SMQ’s sensitivity to change, we calculated a 452 
mixed ANOVA with the three assessment points of the SMQ and group as a between factor. 453 
To further examine change within the two groups, separate Repeated Measurement ANOVAs 454 
were calculated. The level of significance for all analyses was set at α < .05. 455 
 456 
Results 457 
For the sample of Study 3 Cronbach’s α of the SMQ was .88. The SMQ’s correlations 458 
to hypothesized divergent measures are displayed in Table 5. The SMQ correlated significantly 459 
with all measures except positive affect, ranging from -.21 for experiential avoidance to -.50 for 460 
negative affect.  461 
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Concerning sensitivity to change, means, standard deviations, and effect sizes for the 462 
SMQ for both groups are displayed in Table 6. The mixed ANOVA showed a statistically 463 
significant interaction between time and group, Greenhouse–Geisser F(1.86, 144.89) = 8.34, p 464 
< .05, partial η² = .097. Mindfulness changed more in the group receiving the online 465 
transdiagnostic treatment than in the waitlist group. In the separate analysis of the treatment and 466 
waitlist group, a significant effect of time on SMQ scores was found in the treatment group 467 
(Greenhouse–Geisser F(1.73, 58.7) = 13.31, p < .01, partial η² = .28), but not in the waitlist 468 
group (Greenhouse–Geisser F(1.93, 84.99) =2.44 , p =.095, partial η² = .053). The pre- to post-469 
gain in SMQ scores of 10.86 points in the treatment group corresponds to an effect size of .71 470 
(Cohen’s d) suggesting a medium to large effect. These results indicate that the SMQ 471 
questionnaire is sensitive to change, depicting changes in the treatment group where 472 




Study 3 found medium to large significant correlations between the SMQ and symptom 477 
distress, negative affect, and anxiety sensitivity and a small correlation to experiential 478 
avoidance. The SMQ’s correlation to positive affect was non-significant. While this is in line 479 
with other studies that found significant correlations between the SMQ and negative affect 480 
(Chadwick et al., 2008) and psychopathology (Baer et al., 2006), the medium to large 481 
correlations query future studies to examine divergent validity of the SMQ. This was the first 482 
study to explore the SMQ’s sensitivity to change and found that the SMQ captured changes in 483 
mindfulness following treatment. While further research with larger sample sizes is needed, 484 
these results provide preliminary evidence for the SMQ’s utility in psychotherapy process 485 
research.  486 
 487 
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Analysis of overall sample 488 
In the final stage of the study, in order to examine the overall psychometric properties 489 
of the SMQ, data from the non-clinical and clinical sample were combined. As the primary 490 
analyses for the current manuscript were performed at an early stage only data from Study 1 491 
and 2 were included into the following analyses. Therefore, in total 1061 participants were 492 
included. Table 2 and 3 display the SMQ item means, item standard deviations, and one- as 493 
well as four-factor-model loadings for the total sample. Overall, the SMQ-mean score for the 494 
total sample (N = 1061) is 47.85 (SD = 15.04). Cronbach’s α was .89. Kolmogorov-Smirnov 495 
test of normality was applied (Z = 0.04; p = .007) indicating non-normality. However, 496 
additional visual inspection revealed a normal distribution. Bartlett’s test of sphericity was 497 
significant (χ2 (120) = 6415.450, p < .001) and KMO statistic revealed high strength of 498 
correlation among variables with .925, indicating that the sample is suited for factor analysis. 499 
In a next step, CFA was performed indicating a higher  χ²(104, n = 1061) = 1943.05, p < .001, 500 
a higher RMSEA = .129, p < .001, a lower CFI = .885, and a higher SRMR = .075 for the one-501 
factor model compared to the four-factor solution χ²(98, n = 1061) = 1729.1, p < .001; RMSEA 502 
= .125, p < .001; SRMR = .072; CFI = .898. These results suggest a better fit of the four-factor 503 
solution, which is further supported by the Chi-square difference test (p < .001). However, as 504 
indicated by the χ² p-value above .05, the CFI below .9, and the RMSEA above .08, the four-505 
factor model does not display good fit, either (Hooper et al., 2008). Furthermore, measurement 506 
invariance analysis between the clinical and the non-clinical sample showed that model fit 507 
indices differed significantly between the configural model (model 1) and a model in which 508 
factor loadings were constrained (model 2). This holds for the single-factor structure (model 1: 509 
χ²(208) = 1951.3; model 2: χ²(223) = 2160.9, p < .001) as well as the four-factor structure 510 
(model 1: χ²(196) = 1675.7; model 2: χ²(208) = 1801.9, p < .01). 511 
 In a last step, for exploratory reasons, the total SMQ scores were compared between the 512 
community-sample (n = 638, M = 46.40, SD = 14.16), meditators (n = 210, M = 57.82, SD = 513 
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15.05), and the clinical-sample (n = 213, M = 42.35, SD = 13.03). One-way ANOVA indicated 514 
significant differences in SMQ scores between subgroups (F(2, 1058) = 71.81, p < .001). 515 
Scheffe post hoc test showed that the mean in total SMQ scores of each subgroup was different 516 
from the other groups at .05 probability. Correlations between the SMQ and FMI-scores (r = 517 
.66, p < .01) as well as CHIME-scores (r = .73, p < .01) were significant, indicating strong 518 
convergent validity for the total sample (see Table 4). 519 
 520 
General Discussion 521 
As one of the few self-rating mindfulness questionnaires, the SMQ uniquely assesses 522 
individuals’ mindfulness awareness of distressing thoughts, images, and perceptions which 523 
constitute major psychopathological phenomena in a variety of clinical disorders. The overall 524 
study involved three substudies to examine internal consistency and reliability, convergent 525 
validity and factor structure in meditators, non-meditators, and patients with schizophrenia and 526 
with depression as well as divergent validity and treatment sensitivity in patients with emotional 527 
disorders. 528 
Overall, the SMQ displayed excellent internal consistency and moderate convergent 529 
validity when compared with the FMI and CHIME, two frequently used mindfulness 530 
questionnaires in clinical practice and research with a different factor structure. An explanation 531 
for these results might be that the CHIME and FMI do not provide an opportunity to respond 532 
neutrally. Consequently, a bias towards polarized response patterns might be created for clinical 533 
groups which frequently experience cognitive impairment and therefore might find a neutral 534 
response option helpful. The inclusion of a neutral option for responding as in the SMQ 535 
decreases the occurrence of extreme response styles while instead fosters a wider spread of 536 
responses. This can be considered as a systematic and important factor for clinical populations. 537 
Therefore, these results seem to support the utility of the SMQ for clinical groups, as current 538 
results indicate that the SMQ can discriminate between individuals diagnosed with 539 
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schizophrenia or depression, and meditators as well as a community sample. In line with the 540 
original validation study, present outcomes support the reproducibility of the SMQ as the same 541 
relative pattern of differences between groups, as well as similar absolute values in each group 542 
were found (Chadwick et al., 2008). The similarity in SMQ scores between samples of non-543 
meditating English speakers drawn from the UK and German speakers drawn from different 544 
Western European countries raises broader questions about the cross-cultural relevance of the 545 
scales, including similarities and differences in dispositional mindful awareness of distressing 546 
thoughts and images.  547 
 Furthermore, when the classification criteria for the meditating sample are changed to 548 
eight weeks of prior meditation experience, which is comparable to eight-week meditation 549 
programs such as MBSR and MBCT, compared to four weeks of experience as initially applied 550 
in this study, the SMQ scores for the two non-clinical samples remain fairly similar. These 551 
outcomes suggest high generalizability of the results and utility for non-clinical populations 552 
such as extensively practicing meditators, as changes in SMQ mean scores were minor when 553 
narrowing the inclusion criteria for the meditating sample. Among meditators, the expectations 554 
concerning the effects of their practice may be a source of bias for the self-report assessment of 555 
mindfulness, as they might overestimate their mindfulness skills (Grossman, 2008). 556 
Furthermore, as the current study did not assess the exact type of meditation the participants 557 
practice, future research should take a differentiating look on the diverse kinds of mediation 558 
practices and their influence on mindfulness. Nevertheless, in contrast to most studies assessing 559 
mindfulness, the current study provided information on the relationship between mindfulness 560 
scores and current meditation practice. Other studies on this subject mostly conceptualize 561 
meditation experience as the number of years since the individual firstly encountered 562 
meditation, whereas current practice is often neglected as a factor (Bergomi et al., 2015). In the 563 
study, post-hoc testing revealed that experienced meditators with current practice score 564 
significantly higher on the SMQ, compared to those who practiced mediation in the past, but 565 
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not currently. This is in line with studies comparing mindfulness scores of meditators and non-566 
meditators (Bergomi et al., 2015; Carmody & Baer, 2008). 567 
In the original study of Chadwick et al. (2008) an inconclusive factor structure of the 568 
SMQ was reported yet emphasizing a one factor structure. The outcomes of the current study 569 
suggest a four-factor structure for the non-clinical population to be more appropriate. Moreover, 570 
for the total sample, the four-factor solution displayed a better model fit compared to a single-571 
factor structure as indicated by the Chi-square difference test on the one hand, but on the other 572 
hand, the model fit indices still did not indicate a good fit. Most prominently, the high RMSEA 573 
index emphasizes the lack of a good fitting model to conceptualize mindfulness and capture the 574 
underlying factor-structure of the SMQ, suggesting a multifaceted understanding and 575 
conceptualization of mindfulness (Baer et al., 2006). Furthermore, as indicated by the 576 
measurement invariance testing, the SMQ items seem to be comprehended differently by the 577 
clinical and non-clinical sample. The outcomes of the current study therefore favor a four-factor 578 
over a one-factor structure of the SMQ. However, these statements have to be viewed with 579 
caution and further research with a larger clinical sample is needed to examine the construct of 580 
mindfulness. There is no consensus on the factorization of mindfulness in questionnaires so far, 581 
as some researchers argue that there are distinguishable components that are stable across 582 
populations, such as applied in the CHIME (Baer et al., 2004). Other studies conceptualized a 583 
two-factor or a multi-factor solution (for example, the CHIME, Bergomi et al., 2013).  584 
To assess divergent validity, the relationship between the SMQ and measures of 585 
psychopathology (PANAS & BSI-18), anxiety sensitivity (ASI-3), and experiential avoidance 586 
(BEAQ) were explored. Similar to mindfulness, these constructs are discussed as mechanisms 587 
involved in the onset and maintenance of mental disorders which raises the question of their 588 
relation among each other. The current study found medium to large correlations between the 589 
SMQ and BSI-18 total score as well as its subscales anxiety and somatization, negative affect 590 
(PANAS), and anxiety sensitivity (ASI-3) and a small correlation with experiential avoidance 591 
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(BEAQ). A non-significant correlation was observed between the SMQ and positive affect 592 
(PANAS). While the medium to large correlations question the SMQ’s divergent validity, these 593 
findings are in line with the initial validation study (Chadwick et al., 2008) as well as previous 594 
studies that reported correlations between mindfulness and psychopathology, anxiety sensitivity 595 
as well as experiential avoidance (Mahoney et al., 2015; Baer et al., 2006). With these constructs 596 
showing similar conceptualizations, small correlations can be expected to some extent and 597 
further research needs to explore their distinct relation and incremental validity. Contrary to the 598 
hypothesis that the SMQ should correlate higher with measures of mindfulness than with 599 
measures of different constructs, it has been observed that the SMQ correlated lower with the 600 
FMI (r = .38) and CHIME (r = .47) in the clinical sample than with symptom distress (r = -.48), 601 
negative affect (r = -.50), and anxiety sensitivity (r = -.45). A similar pattern was observed by 602 
Baer et al. (2006), as higher correlations were found between experiential avoidance and the 603 
SMQ as between the SMQ and FMI. In addition, in line with the current study results, Bear et 604 
al. (2006) report a similar strength in correlation between the SMQ and FMI as well as SMQ 605 
and symptom distress, albeit lower than in the current study. One could argue that the specific 606 
aspect of mindfulness that is captured by the SMQ, the non-judging perception of negative inner 607 
states, is very closely related to symptoms of emotional disorders, which were prevalent in the 608 
current study. Emotional disorders are characterized by maladaptive reactions to frequently 609 
experienced negative emotions (Barlow et al., 2016). It could be that the SMQ, similar to the 610 
construct of experiential avoidance, taps into that aspect of emotional disorders and therefore is 611 
closer related to distressing thoughts and images captured by psychopathology measures 612 
compared to broader measures of mindfulness in clinical samples. 613 
The study examined treatment sensitivity of the SMQ within a randomized-controlled 614 
trial of an internet-based psychotherapy treatment program with a significant mindfulness 615 
component delivered online for people with depressive, anxiety, or somatic symptom disorders. 616 
Data showed a significant improvement in mindfulness of distressing thoughts and images in 617 
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favor of the treatment group. These results underpin the transdiagnostic nature of mindfulness 618 
and the SMQ’s ability to capture changes in mindfulness following the treatment employed in 619 
the current study. In order to examine the question of whether improved mindfulness of 620 
distressing thoughts and images is an underlying mechanism of change in psychotherapies in 621 
general (Bergomi et al., 2013), future research needs to examine the change in the SMQ score 622 
following psychotherapy that does not directly teach mindfulness. While this delivers 623 
preliminary evidence for the SMQ’s sensitivity to change, these results need to be interpreted 624 
cautiously in the light of the high percentage of missing values. To draw conclusions of the 625 
SMQ’s clinical and research utility, further research is needed to assess the SMQ in a larger 626 
sample. 627 
Limitations and Future Research Directions 628 
The current study should be seen in the light of several limitations. First, there were 629 
high drop-out rates for the sensitivity to change analysis within the randomized controlled trial. 630 
Future research should aim for a larger sample. Therewith, the current results should be 631 
replicated within different therapeutic interventions. Second, a majority of patients’ symptom 632 
severity was not measured through clinical assessments. Here, it might be useful to examine the 633 
relationship between symptom severity, disorder spectrum, and mindfulness abilities. Third, 634 
factor analysis outcomes with ordinal data, such as a Likert-scale should be treated with caution 635 
as they can lead to “over-factoring”, indicating multiple underlying dimensions, even though 636 
the true structure is unidimensional. Future research therefore could employ parallel analysis 637 
for assessing dimensionality and polychoric correlations instead of Pearson correlations (van 638 
der Eijk & Rose, 2015). Lastly, future research needs to investigate test-retest reliability as well 639 
as divergent validity in extended sample sizes and also of clinical groups other than 640 
schizophrenia and depression.  641 
In line with the initial development and validation (Chadwick et al., 2008), the results 642 
of the current study support the SMQ’s value and practicality in clinical practice and research 643 
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in German-speaking areas. The SMQ has particular value in process and outcome assessment 644 
in mindfulness for emotional disorders, as well as being applicable in other clinical applications. 645 
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Table 2. SMQ item mean, item standard deviation, and corrected item-total correlations for all samples as well as R-Square and un-rotated factor 
loadings as reported by Exploratory Factor Analysis for the clinical sample 





SD C. ITC Item 
Mean 
SD C. ITC R2 UFL Item 
Mean 
SD C. ITC Item 
Mean 
SD C. ITC Item 
Mean 
SD C. ITC 
1.   3.30 1.52 0.56 3.04 1.69 0.42 0.55 0.30 3.37 1.46 0.59 3.86 1.33 0.63 3.21 1.47 0.56 
2.  1.60 1.23 0.48 1.62 1.44 0.43 0.49 0.24 1.60 1.18 0.51 1.98 1.26 0.49 1.47 1.12 0.49 
3.  1.95 1.34 0.44 1.86 1.37 0.29 0.33 0.11 1.98 1.33 0.48 2.44 1.53 0.48 1.82 1.22 0.43 
4.  2.91 1.47 0.60 2.56 1.64 0.50 0.65 0.42 3.00 1.41 0.63 3.59 1.31 0.62 2.80 1.38 0.59 
5.  3.83 1.41 0.64 3.17 1.55 0.48 0.63 0.40 3.99 1.33 0.67 4.47 1.20 0.71 3.83 1.33 0.63 
6.  3.80 1.62 0.39 3.42 1.77 0.12 0.14 0.02 3.90 1.56 0.44 4.18 1.47 0.50 3.80 1.58 0.41 
7.  2.94 1.50 0.46 2.76 1.60 0.31 0.47 0.22 2.99 1.48 0.49 3.61 1.39 0.58 2.78 1.45 0.40 
8.  3.29 1.72 0.50 2.78 1.66 0.29 0.32 0.11 3.42 1.71 0.53 3.67 1.68 0.54 3.33 1.71 0.53 
9.  3.25 1.53 0.64 2.70 1.70 0.42 0.57 0.32 3.39 1.46 0.69 3.88 1.36 0.72 3.23 1.45 0.66 
10.  3.11 1.51 0.69 2.91 1.69 0.61 0.75 0.57 3.16 1.46 0.72 3.84 1.32 0.72 2.93 1.43 0.69 
11.  3.69 1.57 0.63 3.13 1.71 0.50 0.65 0.42 3.84 1.50 0.65 4.22 1.37 0.68 3.71 1.52 0.64 
12.  2.64 1.58 0.45 2.29 1.64 0.20 0.21 0.04 2.73 1.56 0.50 3.52 1.56 0.56 2.47 1.47 0.41 
13.  2.26 1.39 0.57 2.17 1.54 0.47 0.51 0.26 2.29 1.35 0.6 2.89 1.50 0.54 2.09 1.24 0.58 
14.  3.12 1.69 0.65 2.41 1.68 0.51 0.55 0.30 3.31 1.64 0.67 4.03 1.56 0.71 3.06 1.60 0.62 
15.  3.12 1.51 0.58 2.76 1.61 0.34 0.49 0.24 3.21 1.47 0.63 4.07 1.28 0.67 2.92 1.42 0.57 
16.  3.03 1.60 0.59 2.77 1.69 0.53 0.58 0.34 3.10 1.57 0.61 3.57 1.55 0.62 2.94 1.54 0.58 
Note. SD = standard deviation, C.ITC = corrected item-total correlation, UFL = unrotated factor loadings 
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Table 3. Factor loadings and R-square as reported by Confirmatory Factor Analysis for the total sample and the non-clinical sample including the 
factors Observing, Letting-go, Non-judgment and Non-Aversion 
 Total sample  Non-clinical sample 
SMQ 
Items: Four-factor model  
One-factor 
model  Four-factor model  
One-factor 
model 
 Ob LG NJ NA R2  FL R2  Ob LG NJ NA R2  FL R2 
1. 0.63 
   
0.40  0.62 0.39  0.67       0.45  0.66 0.44 
7. 0.54       0.29  0.53 0.28  0.56       0.32  0.55 0.30 
9. 0.75       0.56  0.74 0.55  0.79       0.62  0.78 0.61 
16. 0.65       0.42  0.64 0.40  0.67       0.45  0.66 0.44 
4.   0.68     0.47  0.67 0.45    0.70     0.50  0.70 0.49 
10.   0.80     0.64  0.79 0.63    0.84     0.70  0.83 0.70 
2.   0.58     0.33  0.57 0.33    0.62     0.38  0.61 0.37 
13.   0.64     0.41  0.64 0.40    0.68     0.46  0.68 0.46 
5.     0.79   0.63  0.72 0.52      0.83   0.69  0.75 0.56 
6.     0.45   0.21  0.42 0.17      0.50   0.25  0.45 0.20 
12.     0.58   0.33  0.53 0.28      0.62   0.38  0.56 0.31 
14.     0.78   0.60  0.71 0.50      0.81   0.66  0.73 0.54 
11.       0.72 0.52  0.70 0.49        0.77 0.59  0.72 0.52 
15.       0.67 0.44  0.64 0.41        0.73 0.53  0.68 0.46 
3.       0.50 0.25  0.48 0.23        0.55 0.30  0.52 0.27 
8.       0.57 0.32  0.55 0.30        0.61 0.38  0.58 0.34 
Note. Ob = Domain “Observing”; LG = Domain “Letting-go”; NJ = Domain “Non-judgment”; NA = Domain “Non-Aversion”; FL = Factor loading
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Table 4. SMQ Convergent validity. Correlation of SMQ-scores with FMI and CHIME for 
total sample and sub-samples 
Note. **. Significant at .01 (two-tailed) 
 
Table 5. SMQ Divergent validity. Correlation of SMQ-scores with BSI-18 and its subdomains, 
the two PANAS domains, BEAQ and ASI-3 
Note. **. Significant at .01 (two-tailed); *. Significant at .05 (two-tailed) 
 
Table 6. SMQ Sensitivity to change: Comparison between the treatment and waitlist group 
 Treatment group  Waitlist group  
 Mean Std. 
Deviation 




Pre-Assessment 36.0 15.87  34.82 10.96  
module 3 / week 3 assessment 35.89 12.36  32.31 11.23 0.30 
10-week post- intervention / 
waiting period assessment 
46.86 14.49  35.20 12.54 0.86 
Note. Means and standard deviations for the SMQ for the treatment and waitlist group for all 
three assessment points as well as between-group effect sizes (Cohen’s d) for the module / week 






Non-Clinical Sample  
    Community Meditators 
FMI .659** .383** .707** .643** .760** 
CHIME .730** .472** .775** .726** .803** 
BSI-18 PANAS BEAQ ASI-3 







-.48** -.30** -.48** -.26** -.09 -.50** -.21* -.38** 
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Figure 1. Flow chart of the recruitment process 
  
Note. *n = 77 participants have been included from the Charité – Universitätsmedizin Berlin 
and n = 30 from the Freie Universität Berlin 
 
 
